Citigroup’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81K | Sell |
340
-2,571
| -88% | -$13.6K | ﹤0.01% | 4619 |
|
|
2025
Q1 | $12.9K | Buy |
2,911
+1,393
| +92% | +$6.16K | ﹤0.01% | 4385 |
|
|
2024
Q4 | $10.6K | Buy |
1,518
+151
| +11% | +$1.06K | ﹤0.01% | 4517 |
|
|
2024
Q3 | $19.8K | Buy |
1,367
+918
| +204% | +$13.3K | ﹤0.01% | 4400 |
|
|
2024
Q2 | $32.7K | Buy |
449
+68
| +18% | +$4.96K | ﹤0.01% | 4079 |
|
|
2024
Q1 | $22.5K | Buy |
381
+83
| +28% | +$4.91K | ﹤0.01% | 4246 |
|
|
2023
Q4 | $21.8K | Buy |
298
+296
| +14,800% | +$21.7K | ﹤0.01% | 4209 |
|
|
2023
Q3 | $78 | Sell |
2
-620
| -100% | -$24.2K | ﹤0.01% | 4693 |
|
|
2023
Q2 | $35.9K | Sell |
622
-503
| -45% | -$29K | ﹤0.01% | 4122 |
|
|
2023
Q1 | $73.1K | Buy |
+1,125
| New | +$73.1K | ﹤0.01% | 3509 |
|
|
2022
Q4 | – | Sell |
-30
| Closed | -$1K | – | 5054 |
|
|
2022
Q3 | $1K | Sell |
30
-94
| -76% | -$3.13K | ﹤0.01% | 4871 |
|
|
2022
Q2 | $2K | Buy |
124
+18
| +17% | +$290 | ﹤0.01% | 5124 |
|
|
2022
Q1 | $9K | Sell |
106
-324
| -75% | -$27.5K | ﹤0.01% | 4811 |
|
|
2021
Q4 | $39K | Buy |
430
+267
| +164% | +$24.2K | ﹤0.01% | 4421 |
|
|
2021
Q3 | $20K | Buy |
163
+101
| +163% | +$12.4K | ﹤0.01% | 4488 |
|
|
2021
Q2 | $7K | Sell |
62
-20
| -24% | -$2.26K | ﹤0.01% | 5097 |
|
|
2021
Q1 | $12K | Sell |
82
-168
| -67% | -$24.6K | ﹤0.01% | 4895 |
|
|
2020
Q4 | $29K | Buy |
250
+190
| +317% | +$22K | ﹤0.01% | 4429 |
|
|
2020
Q3 | $5K | Sell |
60
-118
| -66% | -$9.83K | ﹤0.01% | 4690 |
|
|
2020
Q2 | $20K | Sell |
178
-188
| -51% | -$21.1K | ﹤0.01% | 4262 |
|
|
2020
Q1 | $40K | Buy |
366
+107
| +41% | +$11.7K | ﹤0.01% | 3955 |
|
|
2019
Q4 | $41K | Buy |
259
+161
| +164% | +$25.5K | ﹤0.01% | 4095 |
|
|
2019
Q3 | $14K | Sell |
98
-244
| -71% | -$34.9K | ﹤0.01% | 4441 |
|
|
2019
Q2 | $39K | Buy |
342
+55
| +19% | +$6.27K | ﹤0.01% | 4263 |
|
|
2019
Q1 | $31K | Buy |
287
+121
| +73% | +$13.1K | ﹤0.01% | 4333 |
|
|
2018
Q4 | $13K | Buy |
166
+4
| +2% | +$313 | ﹤0.01% | 4560 |
|
|
2018
Q3 | $26K | Buy |
+162
| New | +$26K | ﹤0.01% | 4420 |
|